Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Clinical trial NCT00024557 · COMPLETED

Trial details

NCT number: NCT00024557
Sponsor: INSYS Therapeutics Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma Multiforme Anaplastic Astrocytoma Mixed Oligoastrocytoma Malignant Astrocytoma

Start date: 2001-06-01
Primary completion: 2006-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.